BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34822659)

  • 1. A Comparative View on Molecular Alterations and Potential Therapeutic Strategies for Canine Oral Melanoma.
    Hardwick L
    Vet Sci; 2021 Nov; 8(11):. PubMed ID: 34822659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array Comparative Genomic Hybridization Analysis Reveals Significantly Enriched Pathways in Canine Oral Melanoma.
    Brocca G; Ferraresso S; Zamboni C; Martinez-Merlo EM; Ferro S; Goldschmidt MH; Castagnaro M
    Front Oncol; 2019; 9():1397. PubMed ID: 31921654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Analysis of Long Non-Coding RNA Profiles in Canine Oral Melanomas.
    Hitte C; Le Béguec C; Cadieu E; Wucher V; Primot A; Prouteau A; Botherel N; Hédan B; Lindblad-Toh K; André C; Derrien T
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31234577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
    Segaoula Z; Primot A; Lepretre F; Hedan B; Bouchaert E; Minier K; Marescaux L; Serres F; Galiègue-Zouitina S; André C; Quesnel B; Thuru X; Tierny D
    BMC Cancer; 2018 Dec; 18(1):1219. PubMed ID: 30514258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma.
    Prouteau A; Chocteau F; de Brito C; Cadieu E; Primot A; Botherel N; Degorce F; Cornevin L; Lagadic MA; Cabillic F; de Fornel-Thibaud P; Devauchelle P; Derrien T; Abadie J; André C; Hédan B
    Vet Comp Oncol; 2020 Jun; 18(2):214-223. PubMed ID: 31461207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization.
    Poorman K; Borst L; Moroff S; Roy S; Labelle P; Motsinger-Reif A; Breen M
    Chromosome Res; 2015 Jun; 23(2):171-86. PubMed ID: 25511566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma.
    Hirsch D; Kemmerling R; Davis S; Camps J; Meltzer PS; Ried T; Gaiser T
    Cancer Res; 2013 Mar; 73(5):1454-60. PubMed ID: 23271725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on Canine Oral Melanoma: An Undervalued Authentic Genetic Model of Human Oral Melanoma?
    Palma SD; McConnell A; Verganti S; Starkey M
    Vet Pathol; 2021 Sep; 58(5):881-889. PubMed ID: 33685309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma.
    Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M
    Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets.
    Prouteau A; Mottier S; Primot A; Cadieu E; Bachelot L; Botherel N; Cabillic F; Houel A; Cornevin L; Kergal C; Corre S; Abadie J; Hitte C; Gilot D; Lindblad-Toh K; André C; Derrien T; Hedan B
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma.
    Giannuzzi D; Marconato L; Elgendy R; Ferraresso S; Scarselli E; Fariselli P; Nicosia A; Pegolo S; Leoni G; Laganga P; Leone VF; Giantin M; Troise F; Dacasto M; Aresu L
    Vet Comp Oncol; 2019 Sep; 17(3):308-316. PubMed ID: 30805995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
    Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
    Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and genetic diversity in the metastatic process of melanoma.
    Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
    J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Brocca G; Poncina B; Sammarco A; Cavicchioli L; Castagnaro M
    Animals (Basel); 2020 Dec; 10(12):. PubMed ID: 33321993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
    Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
    J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
    Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS
    Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the canonical Wnt/β-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines.
    Chon E; Thompson V; Schmid S; Stein TJ
    J Comp Pathol; 2013 Feb; 148(2-3):178-87. PubMed ID: 22901430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma.
    Violanti SS; Bononi I; Gallenga CE; Martini F; Tognon M; Perri P
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
    Valsesia A; Rimoldi D; Martinet D; Ibberson M; Benaglio P; Quadroni M; Waridel P; Gaillard M; Pidoux M; Rapin B; Rivolta C; Xenarios I; Simpson AJ; Antonarakis SE; Beckmann JS; Jongeneel CV; Iseli C; Stevenson BJ
    PLoS One; 2011 Apr; 6(4):e18369. PubMed ID: 21494657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification.
    Van Bockstal MR; Agahozo MC; van Marion R; Atmodimedjo PN; Sleddens HFBM; Dinjens WNM; Visser LL; Lips EH; Wesseling J; van Deurzen CHM
    Mol Oncol; 2020 Apr; 14(4):671-685. PubMed ID: 32058674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.